FILTER

LATEST INTERVIEWS

Mark Egerton

CEO, QUOTIENT SCIENCES
Quotient Sciences is a drug development and manufacturing accelerator that supports pharmaceutical and biotech companies with services spanning the entire development pathway from candidate selection to commercial launch.

Theo Yameogo

CO-LEADER – MINING AND METALS, ERNST & YOUNG LLP
EY explains how mining is undergoing a transition driven by technology and a clear focus on ESG.

Tom Juric

DIVISIONAL DIRECTOR – MINING, LIEBHERR CANADA
Liebherr explains how it is attempting to build up is share of the Canadian mining equipment market.

Roger Marchioni

ASIA DIRECTOR, CHEMICALS AND POLYMERS, BRASKEM
Braskem speaks to GBR about the goals of its Singapore office.

Jay Shukla

PRESIDENT & CEO, NIVAGEN PHARMACEUTICALS, INC.
Nivagen Pharmaceuticals provides complete research, analytical formulation development, and regulatory support.

Dr. Jagadeesh Babu Rangisetty

FOUNDER & CEO, BIOPHORE
Biophore explains how it is expanding productions of different APIs to ensure both quality and supply chain security.

Dirk Lorenz-Meyer

MEMBER OF THE BOARD, BEHN MEYER GROUP
Behn Meyer Group speaks to GBR about its business in Singapore and SE Asia.

Wim Roels

CEO, BOROUGE
Borouge speaks to GBR about trends affecting its polyethylene and polypropylene solutions business.

Christina Visser

CEO, IONIC TECHNOLOGY GROUP
Ionic Technology Group explains how it is expanding to meet increasing demands for automation and technology by miners.

James Lill

MANAGER, EASTERN CANADA, MINING PLUS
Mining Plus comments on how mechanization and automisation are increasing the productivity, sustainabity and safety of the world’s leading mines.

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

Singapore Chemicals 2021

PARTNER EVENTS